-
1
-
-
0036899604
-
Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001
-
[PMID: 12454235]
-
McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002; 17: 2212-2219 [PMID: 12454235 DOI: 10.1093/ndt/17.12.2212]
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 2212-2219
-
-
McDonald, S.P.1
Russ, G.R.2
-
2
-
-
0037148938
-
Strategies to improve long-term outcomes after renal transplantation
-
[PMID:11856798]
-
Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590 [PMID:11856798 DOI: 10.1056/NEJMra011295]
-
(2002)
N Engl J Med
, vol.346
, pp. 580-590
-
-
Pascual, M.1
Theruvath, T.2
Kawai, T.3
Tolkoff-Rubin, N.4
Cosimi, A.B.5
-
3
-
-
84871849256
-
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study
-
[PMID: 23258810]
-
Morales JM, Marcén R, del Castillo D, Andres A, Gonzalez-Molina M, Oppenheimer F, Serón D, Gil-Vernet S, Lampreave I, Gainza FJ, Valdés F, Cabello M, Anaya F, Escuin F, Arias M, Pallardó L, Bustamante J. Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant 2012; 27 Suppl 4: iv39-iv46 [PMID: 23258810 DOI: 10.1093/ndt/gfs544]
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. iv39-iv46
-
-
Morales, J.M.1
Marcén, R.2
del Castillo, D.3
Andres, A.4
Gonzalez-Molina, M.5
Oppenheimer, F.6
Serón, D.7
Gil-Vernet, S.8
Lampreave, I.9
Gainza, F.J.10
Valdés, F.11
Cabello, M.12
Anaya, F.13
Escuin, F.14
Arias, M.15
Pallardó, L.16
Bustamante, J.17
-
4
-
-
0037182904
-
The changing causes of graft loss and death after kidney transplantation
-
[PMID: 12131689]
-
Howard RJ, Patton PR, Reed AI, Hemming AW, Van der Werf WJ, Pfaff WW, Srinivas TR, Scornik JC. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923-1928 [PMID: 12131689]
-
(2002)
Transplantation
, vol.73
, pp. 1923-1928
-
-
Howard, R.J.1
Patton, P.R.2
Reed, A.I.3
Hemming, A.W.4
Van der Werf, W.J.5
Pfaff, W.W.6
Srinivas, T.R.7
Scornik, J.C.8
-
5
-
-
84896460853
-
Changing pattern of mortality in renal transplant recipients: a single-center, 30-year experience
-
[PMID:24655983]
-
Shu KH, Ho HC, Wen MC, Wu MJ, Chen CH, Cheng CH, Yu TM, Chuang YW, Huang ST, Tsai SF, Lo YC, Weng SC. Changing pattern of mortality in renal transplant recipients: a single-center, 30-year experience. Transplant Proc 2014; 46: 442-444 [PMID:24655983 DOI: 10.1016/j.transproceed.2013.11.032]
-
(2014)
Transplant Proc
, vol.46
, pp. 442-444
-
-
Shu, K.H.1
Ho, H.C.2
Wen, M.C.3
Wu, M.J.4
Chen, C.H.5
Cheng, C.H.6
Yu, T.M.7
Chuang, Y.W.8
Huang, S.T.9
Tsai, S.F.10
Lo, Y.C.11
Weng, S.C.12
-
6
-
-
33751211857
-
Management of hepatitis B and C virus infection before and after renal transplantation
-
Fabrizi F, Martin P. Management of hepatitis B and C virus infection before and after renal transplantation. Curr Opin Organ Transplant 2006; 11: 583-588 [DOI: 10.1097/MOT.0b013e3280105c5c]
-
(2006)
Curr Opin Organ Transplant
, vol.11
, pp. 583-588
-
-
Fabrizi, F.1
Martin, P.2
-
7
-
-
0037850873
-
Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS
-
[PMID: 12753311]
-
Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003; 63: 2222-2229 [PMID: 12753311 DOI: 10.1046/j.1523-1755.2003.00017.x]
-
(2003)
Kidney Int
, vol.63
, pp. 2222-2229
-
-
Burdick, R.A.1
Bragg-Gresham, J.L.2
Woods, J.D.3
Hedderwick, S.A.4
Kurokawa, K.5
Combe, C.6
Saito, A.7
LaBrecque, J.8
Port, F.K.9
Young, E.W.10
-
8
-
-
84861821803
-
Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients
-
[PMID: 22677941]
-
Urbánek P. Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients. Kidney Blood Press Res 2012; 35: 454-467 [PMID: 22677941 DOI: 10.1159/000338309]
-
(2012)
Kidney Blood Press Res
, vol.35
, pp. 454-467
-
-
Urbánek, P.1
-
9
-
-
70349240414
-
Chronic hepatitis B: update 2009
-
[PMID: 19714720]
-
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662 [PMID: 19714720 DOI: 10.1002/hep.23190]
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
10
-
-
84862664371
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
-
[PMID: 22436845]
-
European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-185 [PMID: 22436845 DOI: 10.1016/j.jhep.2012.02.010]
-
(2012)
J Hepatol
, vol.57
, pp. 167-185
-
-
-
11
-
-
84889687049
-
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease
-
[PMID: 24299322]
-
Pipili C, Cholongitas E, Papatheodoridis G. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease. Aliment Pharmacol Ther 2014; 39: 35-46 [PMID: 24299322 DOI: 10.1111/apt.12538]
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 35-46
-
-
Pipili, C.1
Cholongitas, E.2
Papatheodoridis, G.3
-
12
-
-
12144286950
-
Transjugular liver biopsy in patients with end-stage renal disease
-
[PMID: 15028810]
-
Ahmad A, Hasan F, Abdeen S, Sheikh M, Kodaj J, Nampoory MR, Johny KV, Asker H, Siddique I, Thalib L, Al-Nakib B. Transjugular liver biopsy in patients with end-stage renal disease. J Vasc Interv Radiol 2004; 15: 257-260 [PMID: 15028810 DOI: 10.1097/01. RVI.0000109403.52762.C4]
-
(2004)
J Vasc Interv Radiol
, vol.15
, pp. 257-260
-
-
Ahmad, A.1
Hasan, F.2
Abdeen, S.3
Sheikh, M.4
Kodaj, J.5
Nampoory, M.R.6
Johny, K.V.7
Asker, H.8
Siddique, I.9
Thalib, L.10
Al-Nakib, B.11
-
13
-
-
80051820339
-
Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease
-
[PMID: 21738254]
-
García Agudo R, Aoufi Rabih S, Pérez Roldán F, Guzmán Ames F, González Carro P, Ruiz Carrillo F, Cuesta Domínguez R. Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease. Nefrologia 2011; 31: 490-492 [PMID: 21738254 DOI: 10.3265/Nefrologia. pre2011.May.10878]
-
(2011)
Nefrologia
, vol.31
, pp. 490-492
-
-
García Agudo, R.1
Aoufi Rabih, S.2
Pérez Roldán, F.3
Guzmán Ames, F.4
González Carro, P.5
Ruiz Carrillo, F.6
Cuesta Domínguez, R.7
-
14
-
-
60749126501
-
KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
-
[PMID: 18382440]
-
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008; 73 (Suppl 109): S1-99 [PMID: 18382440 DOI: 10.1038/ki.2008.81]
-
(2008)
Kidney Int Suppl
, vol.73
, pp. S1-S99
-
-
-
15
-
-
74949094555
-
KDIGO clinical practice guideline for the care of kidney transplant recipients
-
[PMID:19845597]
-
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 Suppl 3: S1-155 [PMID:19845597 DOI: 10.1111/j.1600-6143.2009.02834.x]
-
(2009)
Am J Transplant
, vol.9
, pp. S1-S155
-
-
-
16
-
-
64249155171
-
Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis
-
[PMID: 19196449]
-
Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transpl Int 2009; 22: 568-573 [PMID: 19196449 DOI: 10.1111/j.1432-2277.2009.00834.x]
-
(2009)
Transpl Int
, vol.22
, pp. 568-573
-
-
Alric, L.1
Kamar, N.2
Bonnet, D.3
Danjoux, M.4
Abravanel, F.5
Lauwers-Cances, V.6
Rostaing, L.7
-
17
-
-
84922042335
-
Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients
-
Jun 25, Epub ahead of print [PMID:25019317]
-
Ruhi C, Süleymanlar I, Koçak H, Dinçkan A, Ersoy F, Süleymanlar G. Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients. Exp Clin Transplant 2014 Jun 25; Epub ahead of print [PMID:25019317 DOI: 10.6002/ect.2013.0280]
-
(2014)
Exp Clin Transplant
-
-
Ruhi, C.1
Süleymanlar, I.2
Koçak, H.3
Dinçkan, A.4
Ersoy, F.5
Süleymanlar, G.6
-
18
-
-
11844299575
-
HBV reactivation after kidney transplantation
-
[PMID: 15653420]
-
Berger A, Preiser W, Kachel HG, Stürmer M, Doerr HW. HBV reactivation after kidney transplantation. J Clin Virol 2005; 32: 162-165 [PMID: 15653420 DOI: 10.1016/j.jcv.2004.10.006]
-
(2005)
J Clin Virol
, vol.32
, pp. 162-165
-
-
Berger, A.1
Preiser, W.2
Kachel, H.G.3
Stürmer, M.4
Doerr, H.W.5
-
19
-
-
84866356153
-
Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection
-
[PMID: 22921412]
-
Kanaan N, Kabamba B, Maréchal C, Pirson Y, Beguin C, Goffin E, Hassoun Z. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. J Clin Virol 2012; 55: 233-238 [PMID: 22921412 DOI: 10.1016/j.jcv.2012.07.015]
-
(2012)
J Clin Virol
, vol.55
, pp. 233-238
-
-
Kanaan, N.1
Kabamba, B.2
Maréchal, C.3
Pirson, Y.4
Beguin, C.5
Goffin, E.6
Hassoun, Z.7
-
20
-
-
0242354871
-
Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation
-
[PMID: 14617300]
-
Duhart BT, Honaker MR, Shokouh-Amiri MH, Riely CA, Vera SR, Taylor SL, Al-jedai AH, Gaber AO. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis 2003; 5: 126-131 [PMID: 14617300 DOI: 10.1034/j.1399-3062.2003.00021.x]
-
(2003)
Transpl Infect Dis
, vol.5
, pp. 126-131
-
-
Duhart, B.T.1
Honaker, M.R.2
Shokouh-Amiri, M.H.3
Riely, C.A.4
Vera, S.R.5
Taylor, S.L.6
Al-jedai, A.H.7
Gaber, A.O.8
-
21
-
-
40849135610
-
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting
-
[PMID: 18203658]
-
Barclay S, Pol S, Mutimer D, Benhamou Y, Mills PR, Hayes PC, Cameron S, Carman W. The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. J Clin Virol 2008; 41: 243-254 [PMID: 18203658 DOI: 10.1016/j.jcv.2007.11.017]
-
(2008)
J Clin Virol
, vol.41
, pp. 243-254
-
-
Barclay, S.1
Pol, S.2
Mutimer, D.3
Benhamou, Y.4
Mills, P.R.5
Hayes, P.C.6
Cameron, S.7
Carman, W.8
-
22
-
-
0037183613
-
Management of chronic viral hepatitis before and after renal transplantation
-
[PMID: 12352899]
-
Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74: 427-437 [PMID: 12352899]
-
(2002)
Transplantation
, vol.74
, pp. 427-437
-
-
Gane, E.1
Pilmore, H.2
-
23
-
-
75749145002
-
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
-
[PMID: 19847156]
-
Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77: 299-311 [PMID: 19847156]
-
(2010)
Kidney Int
, vol.77
, pp. 299-311
-
-
Kasiske, B.L.1
Zeier, M.G.2
Chapman, J.R.3
Craig, J.C.4
Ekberg, H.5
Garvey, C.A.6
Green, M.D.7
Jha, V.8
Josephson, M.A.9
Kiberd, B.A.10
Kreis, H.A.11
McDonald, R.A.12
Newmann, J.M.13
Obrador, G.T.14
Vincenti, F.G.15
Cheung, M.16
Earley, A.17
Raman, G.18
Abariga, S.19
Wagner, M.20
Balk, E.M.21
more..
-
24
-
-
0031614864
-
Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients
-
[PMID: 9664963]
-
Durlik M, Gaciong Z, Rowinska D, Rancewicz Z, Lewandowska D, Kozlowska B, Wyzgal J, Soluch L, Walewska-Zielecka B, Rowinski W, Lao M. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transpl Int 1998; 11 Suppl 1: S135-S139 [PMID: 9664963]
-
(1998)
Transpl Int
, vol.11
, pp. S135-S139
-
-
Durlik, M.1
Gaciong, Z.2
Rowinska, D.3
Rancewicz, Z.4
Lewandowska, D.5
Kozlowska, B.6
Wyzgal, J.7
Soluch, L.8
Walewska-Zielecka, B.9
Rowinski, W.10
Lao, M.11
-
25
-
-
85052408257
-
-
NC 27709, USA: GlaxoSmithKline Research Triangle Park
-
Lamivudine (Epivir®) prescribing information. NC 27709, USA: GlaxoSmithKline Research Triangle Park, 2013
-
(2013)
-
-
-
26
-
-
85052409750
-
-
Foster City, CA 94404, USA: Gilead Sciences, Inc
-
Adefovir (Hepsera®) prescribing information. Foster City, CA 94404, USA: Gilead Sciences, Inc., 2012
-
(2012)
-
-
-
27
-
-
85052409667
-
-
New Jersey 07936, USA: East Hanover
-
Telbivudine (Tyzeka®) Novartis Pharmaceuticals Corporation. New Jersey 07936, USA: East Hanover, 2013
-
(2013)
-
-
-
28
-
-
85052411168
-
-
NJ 08543, USA: Princeton
-
Entecavir (Baraclude®) Bristol-Myers Squibb Company. NJ 08543, USA: Princeton, 2014
-
(2014)
-
-
-
29
-
-
85052411385
-
-
Foster City, CA 94404, USA: Gilead Sciences, Inc.
-
Tenofovir (Viread®) prescribing information. Foster City, CA 94404, USA: Gilead Sciences, Inc., 2013
-
(2013)
-
-
-
30
-
-
1842577541
-
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
-
[PMID: 15077027]
-
Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 2004; 77: 859-864 [PMID: 15077027]
-
(2004)
Transplantation
, vol.77
, pp. 859-864
-
-
Fabrizi, F.1
Dulai, G.2
Dixit, V.3
Bunnapradist, S.4
Martin, P.5
-
31
-
-
77955424877
-
Longterm outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments
-
[PMID: 20562676]
-
Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM. Longterm outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments. Transplantation 2010; 90: 325-330 [PMID: 20562676 DOI: 10.1097/TP.0b013e3181e5b811]
-
(2010)
Transplantation
, vol.90
, pp. 325-330
-
-
Yap, D.Y.1
Tang, C.S.2
Yung, S.3
Choy, B.Y.4
Yuen, M.F.5
Chan, T.M.6
-
32
-
-
10444248883
-
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
-
[PMID: 15618847]
-
Thabut D, Thibault V, Bernard-Chabert B, Mouquet C, Di Martino V, Le Calvez S, Opolon P, Benhamou Y, Bitker MO, Poynard T. Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B. Eur J Gastroenterol Hepatol 2004; 16: 1367-1373 [PMID: 15618847]
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 1367-1373
-
-
Thabut, D.1
Thibault, V.2
Bernard-Chabert, B.3
Mouquet, C.4
Di Martino, V.5
Le Calvez, S.6
Opolon, P.7
Benhamou, Y.8
Bitker, M.O.9
Poynard, T.10
-
33
-
-
3042703006
-
Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients
-
[PMID: 15196068]
-
Chan TM, Tse KC, Tang CS, Lai KN, Ho SK. Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients. Am J Transplant 2004; 4: 1103-1109 [PMID: 15196068 DOI: 10.1111/j.1600-6143.2004.00467.x]
-
(2004)
Am J Transplant
, vol.4
, pp. 1103-1109
-
-
Chan, T.M.1
Tse, K.C.2
Tang, C.S.3
Lai, K.N.4
Ho, S.K.5
-
34
-
-
27744539837
-
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
-
[PMID: 16278590]
-
Fontaine H, Vallet-Pichard A, Chaix ML, Currie G, Serpaggi J, Verkarre V, Varaut A, Morales E, Nalpas B, Brosgart C, Pol S. Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency. Transplantation 2005; 80: 1086-1092 [PMID: 16278590 DOI: 10.1097/01.tp.0000178305.39231.a2]
-
(2005)
Transplantation
, vol.80
, pp. 1086-1092
-
-
Fontaine, H.1
Vallet-Pichard, A.2
Chaix, M.L.3
Currie, G.4
Serpaggi, J.5
Verkarre, V.6
Varaut, A.7
Morales, E.8
Nalpas, B.9
Brosgart, C.10
Pol, S.11
-
35
-
-
19044369343
-
Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection
-
[PMID: 15866639]
-
Garcia A, Mazuecos A, González P, Diaz F, Garcia T, Ceballos M, Rivero M. Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection. Transplant Proc 2005; 37: 1462-1463 [PMID: 15866639 DOI: 10.1016/j.transproceed.2005.02.010]
-
(2005)
Transplant Proc
, vol.37
, pp. 1462-1463
-
-
Garcia, A.1
Mazuecos, A.2
González, P.3
Diaz, F.4
Garcia, T.5
Ceballos, M.6
Rivero, M.7
-
36
-
-
33750931569
-
Treatment of lamivudine-resistant hepatitis B infection in postrenal transplant patients with adefovir dipivoxil: preliminary results
-
[PMID: 17112914]
-
de Silva HJ, Dassanayake AS, Manamperi A, de Silva AP. Treatment of lamivudine-resistant hepatitis B infection in postrenal transplant patients with adefovir dipivoxil: preliminary results. Transplant Proc 2006; 38: 3118-3120 [PMID: 17112914 DOI: 10.1016/j.transproceed.2006.08.186]
-
(2006)
Transplant Proc
, vol.38
, pp. 3118-3120
-
-
de Silva, H.J.1
Dassanayake, A.S.2
Manamperi, A.3
de Silva, A.P.4
-
37
-
-
63249095067
-
Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients
-
[PMID: 19203548]
-
Kamar N, Huart A, Tack I, Alric L, Izopet J, Rostaing L. Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients. Clin Nephrol 2009; 71: 36-42 [PMID: 19203548]
-
(2009)
Clin Nephrol
, vol.71
, pp. 36-42
-
-
Kamar, N.1
Huart, A.2
Tack, I.3
Alric, L.4
Izopet, J.5
Rostaing, L.6
-
38
-
-
79958111465
-
Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
-
[PMID:21486869]
-
Lampertico P, Viganò M, Facchetti F, Invernizzi F, Aroldi A, Lunghi G, Messa PG, Colombo M. Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B. Nephrol Dial Transplant 2011; 26: 2037-2041 [PMID:21486869 DOI: 10.1093/ndt/gfr174]
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2037-2041
-
-
Lampertico, P.1
Viganò, M.2
Facchetti, F.3
Invernizzi, F.4
Aroldi, A.5
Lunghi, G.6
Messa, P.G.7
Colombo, M.8
-
39
-
-
84865613156
-
Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients
-
[PMID: 22939662]
-
Lai HW, Chang CC, Chen TH, Tsai MC, Chen TY, Lin CC. Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients. J Formos Med Assoc 2012; 111: 439-444 [PMID: 22939662 DOI: 10.1016/j.jfma.2011.05.010]
-
(2012)
J Formos Med Assoc
, vol.111
, pp. 439-444
-
-
Lai, H.W.1
Chang, C.C.2
Chen, T.H.3
Tsai, M.C.4
Chen, T.Y.5
Lin, C.C.6
-
40
-
-
84892892578
-
Evolution of hepatitis B management in kidney transplantation
-
[PMID:24574715]
-
Yap DY, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol 2014; 20: 468-474 [PMID:24574715 DOI: 10.3748/wjg.v20.i2.468]
-
(2014)
World J Gastroenterol
, vol.20
, pp. 468-474
-
-
Yap, D.Y.1
Chan, T.M.2
-
41
-
-
84861661443
-
A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients
-
[PMID: 22522918]
-
Hu TH, Tsai MC, Chien YS, Chen YT, Chen TC, Lin MT, Chang KC, Chiu KW. A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients. Antivir Ther 2012; 17: 745-753 [PMID: 22522918 DOI: 10.3851/IMP2097]
-
(2012)
Antivir Ther
, vol.17
, pp. 745-753
-
-
Hu, T.H.1
Tsai, M.C.2
Chien, Y.S.3
Chen, Y.T.4
Chen, T.C.5
Lin, M.T.6
Chang, K.C.7
Chiu, K.W.8
-
42
-
-
52449119593
-
Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients
-
[PMID:18724232]
-
Kamar N, Milioto O, Alric L, El Kahwaji L, Cointault O, Lavayssière L, Sauné K, Izopet J, Rostaing L. Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients. Transplantation 2008; 86: 611-614 [PMID:18724232 DOI: 10.1097/TP.0b013e3181806c8c]
-
(2008)
Transplantation
, vol.86
, pp. 611-614
-
-
Kamar, N.1
Milioto, O.2
Alric, L.3
El Kahwaji, L.4
Cointault, O.5
Lavayssière, L.6
Sauné, K.7
Izopet, J.8
Rostaing, L.9
-
43
-
-
77957339492
-
Entecavir in the treatment of chronic hepatitis B in end stage renal disease and kidney transplantation
-
[DOI: 10.1002/dat.20485]
-
Ridruejo E, Adrover R, Alonso C, Mando OG, Silva MO. Entecavir in the treatment of chronic hepatitis B in end stage renal disease and kidney transplantation. Dial Transplant 2010; 39: 397-400 [DOI: 10.1002/dat.20485]
-
(2010)
Dial Transplant
, vol.39
, pp. 397-400
-
-
Ridruejo, E.1
Adrover, R.2
Alonso, C.3
Mando, O.G.4
Silva, M.O.5
-
44
-
-
84858701309
-
Entecavir in the treatment of chronic hepatitis B in kidney transplantation
-
author reply 999, [PMID: 22075262]
-
Ridruejo E, Adrover R, Mandó OG, Silva MO. Entecavir in the treatment of chronic hepatitis B in kidney transplantation. J Hepatol 2012; 56: 997-998; author reply 999 [PMID: 22075262 DOI: 10.1016/j.jhep.2011.09.019]
-
(2012)
J Hepatol
, vol.56
, pp. 997-998
-
-
Ridruejo, E.1
Adrover, R.2
Mandó, O.G.3
Silva, M.O.4
-
45
-
-
84908334868
-
Entecavir treatment in kidney transplant recipients infected with hepatitis B
-
[PMID: 24974788]
-
Yap DY, Yung S, Tang CS, Seto WK, Ma MK, Mok MM, Kwan LP, Chan GC, Choy BY, Yuen MF, Chan TM. Entecavir treatment in kidney transplant recipients infected with hepatitis B. Clin Transplant 2014; 28: 1010-1015 [PMID: 24974788 DOI: 10.1111/ctr.12410]
-
(2014)
Clin Transplant
, vol.28
, pp. 1010-1015
-
-
Yap, D.Y.1
Yung, S.2
Tang, C.S.3
Seto, W.K.4
Ma, M.K.5
Mok, M.M.6
Kwan, L.P.7
Chan, G.C.8
Choy, B.Y.9
Yuen, M.F.10
Chan, T.M.11
-
46
-
-
77952905778
-
Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B
-
[PMID: 19758269]
-
Tse KC, Yap DY, Tang CS, Yung S, Chan TM. Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B. Clin Transplant 2010; 24: 207-212 [PMID: 19758269 DOI: 10.1111/j.1399-0012.2009.01090.x]
-
(2010)
Clin Transplant
, vol.24
, pp. 207-212
-
-
Tse, K.C.1
Yap, D.Y.2
Tang, C.S.3
Yung, S.4
Chan, T.M.5
-
47
-
-
84885071926
-
Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?
-
[PMID: 24052632]
-
Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol 2013; 24: 1519-1527 [PMID: 24052632 DOI: 10.1681/ASN.2012080857]
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 1519-1527
-
-
Tourret, J.1
Deray, G.2
Isnard-Bagnis, C.3
-
48
-
-
79954731609
-
Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients
-
[PMID: 21325995]
-
Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. Transplantation 2011; 91: 916-920 [PMID: 21325995 DOI: 10.1097/TP.0b013e3182100f59]
-
(2011)
Transplantation
, vol.91
, pp. 916-920
-
-
Daudé, M.1
Rostaing, L.2
Sauné, K.3
Lavayssière, L.4
Basse, G.5
Esposito, L.6
Guitard, J.7
Izopet, J.8
Alric, L.9
Kamar, N.10
-
49
-
-
33845252959
-
Hepatitis B treatment: Lessons for the nephrologist
-
[PMID: 17021602]
-
Olsen SK, Brown RS. Hepatitis B treatment: Lessons for the nephrologist. Kidney Int 2006; 70: 1897-1904 [PMID: 17021602 DOI: 10.1038/sj.ki.5001908]
-
(2006)
Kidney Int
, vol.70
, pp. 1897-1904
-
-
Olsen, S.K.1
Brown, R.S.2
-
50
-
-
84901454701
-
Management of patients with hepatitis B and C before and after liver and kidney transplantation
-
[PMID: 24868325]
-
Pipili C, Cholongitas E. Management of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol 2014; 6: 315-325 [PMID: 24868325 DOI: 10.4254/wjh. v6.i5.315]
-
(2014)
World J Hepatol
, vol.6
, pp. 315-325
-
-
Pipili, C.1
Cholongitas, E.2
-
51
-
-
0035865376
-
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence
-
[PMID: 11233898]
-
Han DJ, Kim TH, Park SK, Lee SK, Kim SB, Yang WS, Park JS, Jung JG, Yu ES, Kim SC. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence. Transplantation 2001; 71: 387-394 [PMID: 11233898]
-
(2001)
Transplantation
, vol.71
, pp. 387-394
-
-
Han, D.J.1
Kim, T.H.2
Park, S.K.3
Lee, S.K.4
Kim, S.B.5
Yang, W.S.6
Park, J.S.7
Jung, J.G.8
Yu, E.S.9
Kim, S.C.10
-
52
-
-
33645059975
-
Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen
-
[PMID:16549158]
-
Filik L, Karakayali H, Moray G, Dalgiç A, Emiroglu R, Ozdemir N, Colak T, Gür G, Yilmaz U, Haberal M. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen. Transplant Proc 2006; 38: 496-498 [PMID:16549158 DOI: 10.1016/j.transproceed.2005.12.047]
-
(2006)
Transplant Proc
, vol.38
, pp. 496-498
-
-
Filik, L.1
Karakayali, H.2
Moray, G.3
Dalgiç, A.4
Emiroglu, R.5
Ozdemir, N.6
Colak, T.7
Gür, G.8
Yilmaz, U.9
Haberal, M.10
-
53
-
-
0036829841
-
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
-
[PMID: 12395336]
-
Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 2002; 36: 1246-1252 [PMID: 12395336 DOI: 10.1053/jhep.2002.36156]
-
(2002)
Hepatology
, vol.36
, pp. 1246-1252
-
-
Chan, T.M.1
Fang, G.X.2
Tang, C.S.3
Cheng, I.K.4
Lai, K.N.5
Ho, S.K.6
-
54
-
-
84878531340
-
Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy
-
[PMID: 23726576]
-
Kim HG, Kim EY, Yu YJ, Kim GH, Jeong JW, Byeon JH, Chung BH, Yang CW. Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy. Transplant Proc 2013; 45: 1374-1378 [PMID: 23726576 DOI: 10.1016/j.transproceed.2013.01. 088]
-
(2013)
Transplant Proc
, vol.45
, pp. 1374-1378
-
-
Kim, H.G.1
Kim, E.Y.2
Yu, Y.J.3
Kim, G.H.4
Jeong, J.W.5
Byeon, J.H.6
Chung, B.H.7
Yang, C.W.8
-
55
-
-
84867690859
-
Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients
-
[PMID: 22541690]
-
Park KS, Yang WS, Han DJ, Park JB, Park JS, Park SK. Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients. Clin Nephrol 2012; 78: 303-311 [PMID: 22541690 DOI: 10.5414/CN107617]
-
(2012)
Clin Nephrol
, vol.78
, pp. 303-311
-
-
Park, K.S.1
Yang, W.S.2
Han, D.J.3
Park, J.B.4
Park, J.S.5
Park, S.K.6
-
56
-
-
66149190943
-
Reactivation of hepatitis B
-
[PMID: 19399803]
-
Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49: S156-S165 [PMID: 19399803 DOI: 10.1002/hep.22945]
-
(2009)
Hepatology
, vol.49
, pp. S156-S165
-
-
Hoofnagle, J.H.1
-
57
-
-
79952015372
-
Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C
-
[PMID: 20720267]
-
Ridruejo E, Díaz C, Michel MD, Soler Pujol G, Martínez A, Marciano S, Mandó OG, Vilches A. Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C. Ann Hepatol 2010; 9: 271-277 [PMID: 20720267]
-
(2010)
Ann Hepatol
, vol.9
, pp. 271-277
-
-
Ridruejo, E.1
Díaz, C.2
Michel, M.D.3
Soler Pujol, G.4
Martínez, A.5
Marciano, S.6
Mandó, O.G.7
Vilches, A.8
-
58
-
-
33644819694
-
HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies
-
[PMID:16303005]
-
Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 2913-2921 [PMID:16303005 DOI: 10.1111/j.1600-6143.2005.01113.x]
-
(2005)
Am J Transplant
, vol.5
, pp. 2913-2921
-
-
Fabrizi, F.1
Martin, P.2
Dixit, V.3
Kanwal, F.4
Dulai, G.5
-
59
-
-
84903818820
-
Hepatitis B and survival after renal transplant: meta-analysis of observational studies
-
Fabrizi F, Dixit V, Martin P, Messa P. Hepatitis B and survival after renal transplant: meta-analysis of observational studies. J Viral Hepat 2014; 21: 542-550 [DOI: 10.1111/jvh.12184]
-
(2014)
J Viral Hepat
, vol.21
, pp. 542-550
-
-
Fabrizi, F.1
Dixit, V.2
Martin, P.3
Messa, P.4
-
60
-
-
84862641072
-
Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
-
[PMID:22414762]
-
Cosconea S, Fontaine H, Méritet JF, Corouge M, Sogni P, Vallet-Pichard A, Mallet V, Legendre C, Pol S. Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection. J Hepatol 2012; 57: 55-60 [PMID:22414762 DOI: 10.1016/j.jhep.2012.02.020]
-
(2012)
J Hepatol
, vol.57
, pp. 55-60
-
-
Cosconea, S.1
Fontaine, H.2
Méritet, J.F.3
Corouge, M.4
Sogni, P.5
Vallet-Pichard, A.6
Mallet, V.7
Legendre, C.8
Pol, S.9
-
61
-
-
84880955388
-
Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
-
[PMID: 23207145]
-
Sperl J, Frankova S, Spicak J, Viklicky O. Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection. J Hepatol 2013; 58: 833-835 [PMID: 23207145 DOI: 10.1016/j.jhep.2012.11.032]
-
(2013)
J Hepatol
, vol.58
, pp. 833-835
-
-
Sperl, J.1
Frankova, S.2
Spicak, J.3
Viklicky, O.4
-
62
-
-
84871553091
-
Long-term outcome of Hepatitis B-positive renal allograft recipients after development of antiviral treatment
-
[PMID:22541689]
-
Park KS, Han DJ, Park JB, Park JS, Park S. Long-term outcome of Hepatitis B-positive renal allograft recipients after development of antiviral treatment. Clin Nephrol 2012; 78: 391-398 [PMID:22541689 DOI: 10.5414/CN107565]
-
(2012)
Clin Nephrol
, vol.78
, pp. 391-398
-
-
Park, K.S.1
Han, D.J.2
Park, J.B.3
Park, J.S.4
Park, S.5
-
63
-
-
21844439208
-
Hepatocellular carcinoma in renal transplant patients
-
[PMID: 15964346]
-
Ridruejo E, Mandó OG, Dávalos M, Díaz C, Vilches A. Hepatocellular carcinoma in renal transplant patients. Transplant Proc 2005; 37: 2086-2088 [PMID: 15964346 DOI: 10.1016/j.transp roceed.2005.03.010]
-
(2005)
Transplant Proc
, vol.37
, pp. 2086-2088
-
-
Ridruejo, E.1
Mandó, O.G.2
Dávalos, M.3
Díaz, C.4
Vilches, A.5
-
64
-
-
84903817465
-
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir
-
[PMID: 24188363]
-
Ridruejo E, Marciano S, Galdame O, Reggiardo MV, Muñoz AE, Adrover R, Cocozzella D, Fernandez N, Estepo C, Mendizábal M, Romero GA, Levi D, Schroder T, Paz S, Fainboim H, Mandó OG, Gadano AC, Silva MO. Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir. J Viral Hepat 2014; 21: 590-596 [PMID: 24188363 DOI: 10.1111/jvh.12200]
-
(2014)
J Viral Hepat
, vol.21
, pp. 590-596
-
-
Ridruejo, E.1
Marciano, S.2
Galdame, O.3
Reggiardo, M.V.4
Muñoz, A.E.5
Adrover, R.6
Cocozzella, D.7
Fernandez, N.8
Estepo, C.9
Mendizábal, M.10
Romero, G.A.11
Levi, D.12
Schroder, T.13
Paz, S.14
Fainboim, H.15
Mandó, O.G.16
Gadano, A.C.17
Silva, M.O.18
-
65
-
-
84897959215
-
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
-
[PMID: 24628837]
-
Cho JH, Lim JH, Park GY, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection. Transpl Infect Dis 2014; 16: 295-303 [PMID: 24628837 DOI: 10.1111/tid.12202]
-
(2014)
Transpl Infect Dis
, vol.16
, pp. 295-303
-
-
Cho, J.H.1
Lim, J.H.2
Park, G.Y.3
Kim, J.S.4
Kang, Y.J.5
Kwon, O.6
Choi, J.Y.7
Park, S.H.8
Kim, Y.L.9
Kim, H.K.10
Huh, S.11
Kim, C.D.12
-
66
-
-
84862881523
-
The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a longterm follow-up
-
[PMID: 21744310]
-
Hu TH, Tsai MC, Chen YT, Chien YS, Hung CH, Chen TC, Tseng PL, Chang KC, Yen YH. The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a longterm follow-up. Hepatol Int 2011; 16: [PMID: 21744310 DOI: 10.1007/s12072-011-9295-6]
-
(2011)
Hepatol Int
, vol.16
-
-
Hu, T.H.1
Tsai, M.C.2
Chen, Y.T.3
Chien, Y.S.4
Hung, C.H.5
Chen, T.C.6
Tseng, P.L.7
Chang, K.C.8
Yen, Y.H.9
-
67
-
-
66149190942
-
Side effects of long-term oral antiviral therapy for hepatitis B
-
[PMID: 19399802]
-
Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 2009; 49: S185-S195 [PMID: 19399802 DOI: 10.1002/hep.22885]
-
(2009)
Hepatology
, vol.49
, pp. S185-S195
-
-
Fontana, R.J.1
-
68
-
-
84897603558
-
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment
-
[PMID:24372662]
-
Fung J, Seto WK, Lai CL, Yuen MF. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment. J Gastroenterol Hepatol 2014; 29: 428-434 [PMID:24372662 DOI: 10.1111/jgh.12499]
-
(2014)
J Gastroenterol Hepatol
, vol.29
, pp. 428-434
-
-
Fung, J.1
Seto, W.K.2
Lai, C.L.3
Yuen, M.F.4
-
69
-
-
84890633973
-
Telbivudine improves renal function in patients with chronic hepatitis B
-
[PMID: 24067879]
-
Gane EJ, Deray G, Liaw YF, Lim SG, Lai CL, Rasenack J, Wang Y, Papatheodoridis G, Di Bisceglie A, Buti M, Samuel D, Uddin A, Bosset S, Trylesinski A. Telbivudine improves renal function in patients with chronic hepatitis B. Gastroenterology 2014; 146: 138-146.e5 [PMID: 24067879 DOI: 10.1053/j.gastro.2013.09.031]
-
(2014)
Gastroenterology
, vol.146
, pp. 138-146
-
-
Gane, E.J.1
Deray, G.2
Liaw, Y.F.3
Lim, S.G.4
Lai, C.L.5
Rasenack, J.6
Wang, Y.7
Papatheodoridis, G.8
Di Bisceglie, A.9
Buti, M.10
Samuel, D.11
Uddin, A.12
Bosset, S.13
Trylesinski, A.14
-
70
-
-
84890612444
-
Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects
-
[PMID:24275236]
-
Yapali S, Lok AS. Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects. Gastroenterology 2014; 146: 15-19 [PMID:24275236 DOI: 10.1053/j.gastro.2013.11.028]
-
(2014)
Gastroenterology
, vol.146
, pp. 15-19
-
-
Yapali, S.1
Lok, A.S.2
-
71
-
-
70349230970
-
Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil
-
[PMID: 19517525]
-
Ha NB, Ha NB, Garcia RT, Trinh HN, Vu AA, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology 2009; 50: 727-734 [PMID: 19517525 DOI: 10.1002/hep.23044]
-
(2009)
Hepatology
, vol.50
, pp. 727-734
-
-
Ha, N.B.1
Ha, N.B.2
Garcia, R.T.3
Trinh, H.N.4
Vu, A.A.5
Nguyen, H.A.6
Nguyen, K.K.7
Levitt, B.S.8
Nguyen, M.H.9
-
72
-
-
84862957095
-
Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients
-
[PMID: 21777281]
-
Kim YJ, Cho HC, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients. J Gastroenterol Hepatol 2012; 27: 306-312 [PMID: 21777281 DOI: 10.1111/j.1440-1746.2011.06852.x]
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 306-312
-
-
Kim, Y.J.1
Cho, H.C.2
Sinn, D.H.3
Gwak, G.Y.4
Choi, M.S.5
Koh, K.C.6
Paik, S.W.7
Yoo, B.C.8
Lee, J.H.9
-
73
-
-
84874661218
-
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B
-
[PMID: 23432107]
-
Hartono JL, Aung MO, Dan YY, Gowans M, Lim K, Lee YM, Lee GH, Low HC, Tan PS, Thwin MA, Soon C, Chiu LL, Khoo MJ, Koay E, Lim SG. Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B. Aliment Pharmacol Ther 2013; 37: 710-719 [PMID: 23432107 DOI: 10.1111/apt.12251]
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 710-719
-
-
Hartono, J.L.1
Aung, M.O.2
Dan, Y.Y.3
Gowans, M.4
Lim, K.5
Lee, Y.M.6
Lee, G.H.7
Low, H.C.8
Tan, P.S.9
Thwin, M.A.10
Soon, C.11
Chiu, L.L.12
Khoo, M.J.13
Koay, E.14
Lim, S.G.15
-
74
-
-
80053938419
-
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
-
[PMID: 22093327]
-
Manolakopoulos S, Striki A, Deutsch M, Mela M, Ketikoglou I, Tzourmakliotis D, Manesis EK, Papatheodoridis GV. Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients. Liver Int 2011; 31: 1525-1532 [PMID: 22093327 DOI: 10.1111/j.1478-3231.2011.02616.x]
-
(2011)
Liver Int
, vol.31
, pp. 1525-1532
-
-
Manolakopoulos, S.1
Striki, A.2
Deutsch, M.3
Mela, M.4
Ketikoglou, I.5
Tzourmakliotis, D.6
Manesis, E.K.7
Papatheodoridis, G.V.8
-
75
-
-
84897598448
-
Effects of tenofovir disoproxil fumarate on renal function in chronic HBV patients in three global randomized studies
-
Marcellin P, Heathcote EJ, Berg T, Anderson J, Mondou E, Coombs D, Ebrahimi R, Reddy S, Lopatin U, McNally J, Ng C. Effects of tenofovir disoproxil fumarate on renal function in chronic HBV patients in three global randomized studies. J Hepatol 2011; 54 (Suppl 1): S296-297 [DOI: 10.1016/S0168-8278(11)60741-1]
-
(2011)
J Hepatol
, vol.54
, pp. S296-297
-
-
Marcellin, P.1
Heathcote, E.J.2
Berg, T.3
Anderson, J.4
Mondou, E.5
Coombs, D.6
Ebrahimi, R.7
Reddy, S.8
Lopatin, U.9
McNally, J.10
Ng, C.11
-
76
-
-
84890869059
-
Tenofovir DF (TDF) is safe and well tolerated in chronic hepatitis B (CHB) patients with pre-existing mild renal impairment
-
Fung S, Kwan P, Horban A, Pelemis M, Husa P, Hann HW, Flaherty J, Massetto B, Dinh P, Custodio J, Subramanian GM, Fabri M, Gane E. Tenofovir DF (TDF) is safe and well tolerated in chronic hepatitis B (CHB) patients with pre-existing mild renal impairment. J Hepatol 2013; 58 (Suppl 1): S301-302. [DOI: 10.1016/S0168-8278(13)60746-1]
-
(2013)
J Hepatol
, vol.58
, pp. S301-302
-
-
Fung, S.1
Kwan, P.2
Horban, A.3
Pelemis, M.4
Husa, P.5
Hann, H.W.6
Flaherty, J.7
Massetto, B.8
Dinh, P.9
Custodio, J.10
Subramanian, G.M.11
Fabri, M.12
Gane, E.13
-
77
-
-
84878189466
-
Tenofovir DF treatment is safe and well tolerated in chronic hepatitis B (CHB) patients with baseline decreased glomerular filtration rate
-
Marcellin P, Zoulim F, Causse X, Hézode C, Larrey D, Pageaux G, Roche B, Truchi R, Ouzan D, Pauwels A, Dumortier J, Stern C, Libert O, Cadranel JF, Zarski JP, Vireal Group. Tenofovir DF treatment is safe and well tolerated in chronic hepatitis B (CHB) patients with baseline decreased glomerular filtration rate. J Hepatol 2012; 56 (Suppl 1): S210 [DOI: 10.1016/S0168-8278(12)60544-3]
-
(2012)
J Hepatol
, vol.56
, pp. S210
-
-
Marcellin, P.1
Zoulim, F.2
Causse, X.3
Hézode, C.4
Larrey, D.5
Pageaux, G.6
Roche, B.7
Truchi, R.8
Ouzan, D.9
Pauwels, A.10
Dumortier, J.11
Stern, C.12
Libert, O.13
Cadranel, J.F.14
Zarski, J.P.15
-
78
-
-
79960600600
-
Renal safety and antiviral efficacy of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue refractory patients with hepatitis B virus (HBV) mono-infection
-
van Bommel F, De Man RA, Ferenci P, Reijnders JG, Bronowicki JP, Wedemeyer H, Brodzinski A, Fülöp B, Deterding K, Erhardt A, Hüppe D, Bourlière M, Sarrazin C, Trojan J, Buggisch PB, Petersen J, Spengler U, Pariente A, Schuchmann M, Wasmuth H, Stein K, Rutter K, Feucht HH, Wiedenmann B, Berg T. Renal safety and antiviral efficacy of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue refractory patients with hepatitis B virus (HBV) mono-infection. J Hepatol 2010; 52 (Suppl 1): S398 [DOI: 10.1016/S0168-8278(10)61029-X]
-
(2010)
J Hepatol
, vol.52
, pp. S398
-
-
van Bommel, F.1
De Man, R.A.2
Ferenci, P.3
Reijnders, J.G.4
Bronowicki, J.P.5
Wedemeyer, H.6
Brodzinski, A.7
Fülöp, B.8
Deterding, K.9
Erhardt, A.10
Hüppe, D.11
Bourlière, M.12
Sarrazin, C.13
Trojan, J.14
Buggisch, P.B.15
Petersen, J.16
Spengler, U.17
Pariente, A.18
Schuchmann, M.19
Wasmuth, H.20
Stein, K.21
Rutter, K.22
Feucht, H.H.23
Wiedenmann, B.24
Berg, T.25
more..
-
79
-
-
84922479149
-
Tenofovir monotherapy versus lamivudine plus adefovir in lamivudinefailure patients rescued with lamivudine plus adefovir combination: interim analysis of the TENOSIMP-B clinical trial
-
Jorquera F, Pascasio JM, Fraga E, Fuentes J, Prieto M, Sánchez-Antolín G, Calleja JL, Molina E, Tomé S, Bonet L, Blanco MA, García-Buey ML, Salmerón J, Pons JA, González JM, Rodríguez M. Tenofovir monotherapy versus lamivudine plus adefovir in lamivudinefailure patients rescued with lamivudine plus adefovir combination: interim analysis of the TENOSIMP-B clinical trial. J Hepatol 2014; 60 (Suppl 1): S422 [DOI: 10.1016/S0168-8278(14)61201-0]
-
(2014)
J Hepatol
, vol.60
, pp. S422
-
-
Jorquera, F.1
Pascasio, J.M.2
Fraga, E.3
Fuentes, J.4
Prieto, M.5
Sánchez-Antolín, G.6
Calleja, J.L.7
Molina, E.8
Tomé, S.9
Bonet, L.10
Blanco, M.A.11
García-Buey, M.L.12
Salmerón, J.13
Pons, J.A.14
González, J.M.15
Rodríguez, M.16
-
80
-
-
84860139299
-
Prevalence of renal alterations indicative for proximal tubular damage (PTD) in patients with chronic hepatitis B virus (HBV) infection during long-term treatment with tenofovir disoproxil fumarate (TDF)
-
Brodzinski A, Fueloep B, Schlosser B, Biermer M, Wiegand J, Berg T, van Bommel F. Prevalence of renal alterations indicative for proximal tubular damage (PTD) in patients with chronic hepatitis B virus (HBV) infection during long-term treatment with tenofovir disoproxil fumarate (TDF). Hepatology 2010; 52 (Suppl 1): 515-6A
-
(2010)
Hepatology
, vol.52
, pp. 515A-5166A
-
-
Brodzinski, A.1
Fueloep, B.2
Schlosser, B.3
Biermer, M.4
Wiegand, J.5
Berg, T.6
van Bommel, F.7
-
81
-
-
84901403605
-
Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis
-
Lampertico P, Soffredini R, Yurdaydin C, Idilman R, Papatheodoridis GV, Margariti E, Buti M, Esteban R, Zaltron S, Vavassori A, Castelli C, Viganò M, Rumi MG, Vinci M, Belli LS, Cologni G, Rizzi M, Milanese M, Strazzabosco M, Minola E, Giorgini AM, Zuin M, Salmi A, Colombo S, Fracassetti O, Del Poggio P, Bruno S, Fagiuoli S, Andreoletti M, Colli A, Colombo AE, Bellati GA, Magni CF, Angeli E, Gubertini GA, Fasano M, Santantonio TA, Terreni NM, Mangia G, Colombo M. Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis. Hepatology 2013; 58 (Suppl 1): 653A
-
(2013)
Hepatology
, vol.58
, pp. 653A
-
-
Lampertico, P.1
Soffredini, R.2
Yurdaydin, C.3
Idilman, R.4
Papatheodoridis, G.V.5
Margariti, E.6
Buti, M.7
Esteban, R.8
Zaltron, S.9
Vavassori, A.10
Castelli, C.11
Viganò, M.12
Rumi, M.G.13
Vinci, M.14
Belli, L.S.15
Cologni, G.16
Rizzi, M.17
Milanese, M.18
Strazzabosco, M.19
Minola, E.20
Giorgini, A.M.21
Zuin, M.22
Salmi, A.23
Colombo, S.24
Fracassetti, O.25
Del Poggio, P.26
Bruno, S.27
Fagiuoli, S.28
Andreoletti, M.29
Colli, A.30
Colombo, A.E.31
Bellati, G.A.32
Magni, C.F.33
Angeli, E.34
Gubertini, G.A.35
Fasano, M.36
Santantonio, T.A.37
Terreni, N.M.38
Mangia, G.39
Colombo, M.40
more..
-
82
-
-
84897596291
-
Do tenofovir and entecavir affect renal function in patients with chronic hepatitis B (CHB)? A two-year observational study from a single Australian centre
-
Le ST, Sahhar L, Lim J, He T, Ha P, Rusli F, Ratnam D, Moore GT, Pianko S, Dev A, Polkinghorne K, Sievert W. Do tenofovir and entecavir affect renal function in patients with chronic hepatitis B (CHB)? A two-year observational study from a single Australian centre. Hepatology 2012; 56 (Suppl 1): 410A
-
(2012)
Hepatology
, vol.56
, pp. 410A
-
-
Le, S.T.1
Sahhar, L.2
Lim, J.3
He, T.4
Ha, P.5
Rusli, F.6
Ratnam, D.7
Moore, G.T.8
Pianko, S.9
Dev, A.10
Polkinghorne, K.11
Sievert, W.12
-
83
-
-
84897659481
-
A single centre, large "real-life" cohort treated with tenofovir versus entecavir: no deterioration in renal function in tenofovir cohort over 12 months of therapy
-
Nguyen HL, Al-Freah MA, Joe D, Carey I, Boyer T, Suddle A, Harrison PM, Agarwal K. A single centre, large "real-life" cohort treated with tenofovir versus entecavir: no deterioration in renal function in tenofovir cohort over 12 months of therapy. Hepatology 2011; 54 (Suppl 1): 604A
-
(2011)
Hepatology
, vol.54
, pp. 604A
-
-
Nguyen, H.L.1
Al-Freah, M.A.2
Joe, D.3
Carey, I.4
Boyer, T.5
Suddle, A.6
Harrison, P.M.7
Agarwal, K.8
-
84
-
-
84864106252
-
Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B
-
quiz e68, [PMID: 22507876]
-
Gish RG, Clark MD, Kane SD, Shaw RE, Mangahas MF, Baqai S. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B. Clin Gastroenterol Hepatol 2012; 10: 941-946; quiz e68 [PMID: 22507876 DOI: 10.1016/j.cgh.2012.04.008]
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 941-946
-
-
Gish, R.G.1
Clark, M.D.2
Kane, S.D.3
Shaw, R.E.4
Mangahas, M.F.5
Baqai, S.6
-
85
-
-
80053935254
-
Risk of renal toxicity with tenofovir DF (TDF) for chronic hepatitis B (CHB)
-
Gish R, Mangahas M, Baqai S, Shaw R. Risk of renal toxicity with tenofovir DF (TDF) for chronic hepatitis B (CHB). J Hepatol 2010; 52 (Suppl 1): S388-389 [DOI: 10.1016/S0168-8278(10)61008-2]
-
(2010)
J Hepatol
, vol.52
, pp. S388-S389
-
-
Gish, R.1
Mangahas, M.2
Baqai, S.3
Shaw, R.4
-
86
-
-
81355149665
-
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
-
[PMID: 21703180]
-
Mauss S, Berger F, Filmann N, Hueppe D, Henke J, Hegener P, Athmann C, Schmutz G, Herrmann E. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol 2011; 55: 1235-1240 [PMID: 21703180 DOI: 10.1016/j.jhep.2011.03.030]
-
(2011)
J Hepatol
, vol.55
, pp. 1235-1240
-
-
Mauss, S.1
Berger, F.2
Filmann, N.3
Hueppe, D.4
Henke, J.5
Hegener, P.6
Athmann, C.7
Schmutz, G.8
Herrmann, E.9
-
87
-
-
84860159427
-
Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
-
[PMID: 22417072]
-
Ridruejo E, Silva MO. Safety of long-term nucleos(t)ide treatment in chronic hepatitis B. Expert Opin Drug Saf 2012; 11: 357-360 [PMID: 22417072 DOI: 10.1517/14740338.2012.672972]
-
(2012)
Expert Opin Drug Saf
, vol.11
, pp. 357-360
-
-
Ridruejo, E.1
Silva, M.O.2
|